Biomakers
PrivateLast Round
Seed Round
Apr 29, 2026
Total Funding Raised
$11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biomakers is a biotechnology company that provides a precision medicine and oncology intelligence platform transforming clinical and genomic information into actionable insights for therapeutic and diagnostic development.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomakers Comparables
Compare Biomakers with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempus | 77% | |
| Verana Health | 76% | |
| Pahtia Technologies | 76% |
Biomakers Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 29, 2026 | ||||
| Series A | Jan 21, 2026 | ||||
| SAFE | Dec 16, 2021 |
Biomakers Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Series A |
| Sonen Capital | Series A |
| SV Latam Capital | Series A, SAFE |
| Sky High VC | Series A |
| Oncology Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Raised $6M in seed funding.
- Jan 21, 2026
Raised $8M from Labcorp Venture Fund and others.
Biomakers Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biomakers's valuation, stock price, and market status.
Is Biomakers a public or private company?
Biomakers is a private company.
What is the current stock price of Biomakers?
Biomakers is a private company with no public stock price. No recent secondary market data is available.
How much is Biomakers worth (valuation)?
Valuation information for Biomakers is not publicly available.
Can I buy Biomakers stock?
Biomakers shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biomakers's last funding round?
Biomakers's most recent funding round was Seed Round on April 29, 2026.
Who are the main investors in Biomakers?
Key investors in Biomakers include SV Latam Capital.
Will Biomakers IPO soon?
No public IPO plans have been announced for Biomakers.
How can I track Biomakers secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biomakers's secondary market activity and sign up for updates.